Author:
Liu Dong-Wei,Zhang Jia-Hui,Liu Feng-Xun,Wang Xu-Tong,Pan Shao-Kang,Jiang Deng-Ke,Zhao Zi-Hao,Liu Zhang-Suo
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry
Reference31 articles.
1. Tsai, Y. C. et al. Angiopoietin-2, renal deterioration, major adverse cardiovascular events and all-cause mortality in patients with diabetic nephropathy. Kidney Blood Press. Res. 43, 545–554 (2018).
2. Oates, P. J. Aldose reductase inhibitors and diabetic kidney disease. Curr. Opin. Invest. Drugs 11, 402–417 (2010).
3. Zhu, L., Han, J., Yuan, R., Xue, L. & Pang, W. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-kappaB pathway. Biol. Res. 51, 9 (2018).
4. Gagliardini, E. et al. B7-1 is not induced in podocytes of human and experimental diabetic nephropathy. J. Am. Soc. Nephrol. 27, 999–1005 (2016).
5. Ma, L. et al. Association of EPHX2 R287Q polymorphism with diabetic nephropathy in Chinese type 2 diabetic patients. J. Diabetes Res. 2018, 2786470 (2018).
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献